UA88509C2 - Сублінгвальна таблетка з покриттям, що містить опіоїдний анальгетик - Google Patents

Сублінгвальна таблетка з покриттям, що містить опіоїдний анальгетик

Info

Publication number
UA88509C2
UA88509C2 UAA200710340A UAA200710340A UA88509C2 UA 88509 C2 UA88509 C2 UA 88509C2 UA A200710340 A UAA200710340 A UA A200710340A UA A200710340 A UAA200710340 A UA A200710340A UA 88509 C2 UA88509 C2 UA 88509C2
Authority
UA
Ukraine
Prior art keywords
opioid analgesic
coated tablet
sublingual coated
active substance
sublingual
Prior art date
Application number
UAA200710340A
Other languages
English (en)
Russian (ru)
Inventor
Паскаль Ури
Гием Бенуа
Катрин Эрри
Йозеф Дювошель
Original Assignee
Этифарм
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Этифарм filed Critical Этифарм
Publication of UA88509C2 publication Critical patent/UA88509C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Formation And Processing Of Food Products (AREA)

Abstract

Винахід стосується сублінгвальної таблетки з покриттям, яка містить серцевину, вільну від фармацевтично активної речовини, що містить один чи більше розріджувачів, та покриття, яке містить щонайменше один опіоїдний анальгетик, придатний для сублінгвального введення. Винахід також стосується способу одержання такої таблетки та її застосування для лікування болю.
UAA200710340A 2005-03-18 2006-03-20 Сублінгвальна таблетка з покриттям, що містить опіоїдний анальгетик UA88509C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe

Publications (1)

Publication Number Publication Date
UA88509C2 true UA88509C2 (uk) 2009-10-26

Family

ID=35309611

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710340A UA88509C2 (uk) 2005-03-18 2006-03-20 Сублінгвальна таблетка з покриттям, що містить опіоїдний анальгетик

Country Status (25)

Country Link
US (2) US8709479B2 (uk)
EP (1) EP1858491B1 (uk)
JP (1) JP5138577B2 (uk)
KR (1) KR101239926B1 (uk)
CN (1) CN101141951B (uk)
AT (1) ATE507824T1 (uk)
AU (1) AU2006224690B2 (uk)
BR (1) BRPI0608505B8 (uk)
CA (1) CA2599502C (uk)
CY (1) CY1111729T1 (uk)
DE (1) DE602006021713D1 (uk)
DK (1) DK1858491T3 (uk)
ES (1) ES2365984T3 (uk)
FR (1) FR2883179B1 (uk)
IL (1) IL185626A (uk)
MX (1) MX2007011440A (uk)
NO (1) NO338771B1 (uk)
NZ (1) NZ561154A (uk)
PL (1) PL1858491T3 (uk)
PT (1) PT1858491E (uk)
RU (1) RU2403043C2 (uk)
SI (1) SI1858491T1 (uk)
UA (1) UA88509C2 (uk)
WO (1) WO2006097361A1 (uk)
ZA (1) ZA200707900B (uk)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2549642C (en) * 2003-12-31 2012-10-30 Cima Labs Inc. Effervescent oral opiate dosage forms and methods of administering opiates
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
CN101378732A (zh) * 2006-01-06 2009-03-04 阿塞尔Rx制药有限公司 用于口腔经粘膜递送的生物粘附药物制剂
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
KR101445891B1 (ko) * 2007-01-05 2014-10-02 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 제형의 투여를 위한 저장 및 분배 장치
WO2008100434A1 (en) * 2007-02-09 2008-08-21 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
CN101820838B (zh) * 2007-08-07 2013-06-05 阿塞尔Rx制药有限公司 采用口腔经粘膜剂型的用于程序镇静和镇痛的组合物和方法
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
US20090263476A1 (en) * 2008-04-16 2009-10-22 Jobdevairakkam Christopher N Composition of Rapid Disintegrating Direct Compression Buccal Tablet
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
PT2952191T (pt) * 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil
EP2455069A1 (de) * 2010-11-11 2012-05-23 Laburnum GMBH Wirkstofffreie Darreichungsform, Verfahren zu deren Herstellung sowie deren Verwendung
PH12013501345A1 (en) * 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
KR102158948B1 (ko) * 2011-05-13 2020-09-24 이비 아이피 하이브리탭스 비.브이. 약물 전달 시스템
SMT202100546T1 (it) 2011-09-19 2021-11-12 Orexo Ab Compresse per via sublinguale resistenti all'abuso comprendenti buprenorfina e naloxone
SMT201800585T1 (it) 2012-05-02 2019-01-11 Orexo Ab Nuova composizione di alfentanil per il trattamento di dolore acuto
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP2886103A1 (en) * 2013-12-23 2015-06-24 Hexal AG Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3578164A1 (en) * 2018-06-05 2019-12-11 Bio-Gate AG Thixotropic composition
JP7657457B2 (ja) * 2018-10-19 2025-04-07 ノバ サウスイースタン ユニバーシティー ｐＨ修飾賦形剤及び浸入促進剤を含む舌下エピネフリン組成物及びそれを使用する方法
CN209673136U (zh) 2019-05-07 2019-11-22 深圳市华普森电子有限公司 高清智能一体化管道探测器
JP2022141158A (ja) * 2021-03-15 2022-09-29 株式会社パウレック コーティング錠
WO2025170507A1 (en) * 2024-02-07 2025-08-14 Oncozenge Ab A lozenge

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621954A (uk) * 1961-09-10
US5288498A (en) 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
FR2621483B1 (fr) * 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
WO1994009762A1 (en) * 1992-11-05 1994-05-11 Merck & Co., Inc. Drug delivery device
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5744164A (en) 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2769524B1 (fr) * 1998-01-06 1999-12-31 Ethypharm Lab Prod Ethiques Dispositif d'enrobage pour granules a absorber par voie orale
FR2774910B1 (fr) 1998-02-16 2001-09-07 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US20010016593A1 (en) * 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
BR0212019A (pt) 2001-08-06 2005-08-09 Euro Celtique Sa Formas de dosagem, métodos para o tratamento da dor, métodos de preparação de uma forma de dosagem e métodos para impedir o abuso de uma forma de dosagem
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
JP2006516616A (ja) * 2003-01-31 2006-07-06 オレクソ・アクチエボラゲット 即効薬剤組成物
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe

Also Published As

Publication number Publication date
MX2007011440A (es) 2007-11-14
ES2365984T3 (es) 2011-10-14
RU2403043C2 (ru) 2010-11-10
NZ561154A (en) 2010-12-24
EP1858491A1 (en) 2007-11-28
FR2883179A1 (fr) 2006-09-22
CN101141951A (zh) 2008-03-12
WO2006097361A1 (en) 2006-09-21
HK1109730A1 (en) 2008-06-20
CA2599502C (en) 2013-05-14
US8709479B2 (en) 2014-04-29
CA2599502A1 (en) 2006-09-21
RU2007138647A (ru) 2009-04-27
DK1858491T3 (da) 2011-08-22
BRPI0608505B8 (pt) 2021-05-25
PT1858491E (pt) 2011-08-18
US20080226717A1 (en) 2008-09-18
JP2008533084A (ja) 2008-08-21
BRPI0608505A2 (pt) 2010-01-05
KR20070114756A (ko) 2007-12-04
PL1858491T3 (pl) 2012-03-30
SI1858491T1 (sl) 2011-09-30
IL185626A0 (en) 2008-01-06
NO20075345L (no) 2007-12-17
NO338771B1 (no) 2016-10-17
AU2006224690B2 (en) 2011-09-29
JP5138577B2 (ja) 2013-02-06
ATE507824T1 (de) 2011-05-15
IL185626A (en) 2014-09-30
CY1111729T1 (el) 2015-10-07
EP1858491B1 (en) 2011-05-04
KR101239926B1 (ko) 2013-03-07
AU2006224690A1 (en) 2006-09-21
DE602006021713D1 (de) 2011-06-16
CN101141951B (zh) 2011-02-09
ZA200707900B (en) 2009-01-28
BRPI0608505B1 (pt) 2021-05-04
FR2883179B1 (fr) 2009-04-17
US20060210632A1 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
UA88509C2 (uk) Сублінгвальна таблетка з покриттям, що містить опіоїдний анальгетик
UA88168C2 (uk) Препарат у вигляді таблетки саксагліптину з покриттям і спосіб його виготовлення
MX2008015731A (es) Tabletas sublinguales de baja dosificacion de analgesicos opiaiceos y proceso de preparacion.
WO2005092297A3 (en) A stable pharmaceutical composition comprising an acid labile drug
MXPA05012637A (es) Tableta de liberacion modificada del clorhidrato de bupropion.
MY153092A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
WO2012085657A3 (en) Tamper resistant solid oral dosage forms
WO2004093819A3 (en) Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
WO2005089718A3 (en) Pharmaceutical compositions
MY141194A (en) Process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
GEP20084468B (en) Gamma-d crystalline form of ivabradin hydrochloride, process for its preparation and pharmaceutical compositions containing it
SI1598333T1 (sl) Postopek za pripravo (1s)-4,5-dimetoksi-1-(metilaminometil)-benzociklobutana in njegovih adicijskih soli, kot tudi uporaba za sintezo ivabradina in njegovih adicijskih soli s farmacevtsko sprejemljivo kislino
AU2003216620A1 (en) Method of stabilizing bupropion hydrochloride tablets
WO2010070449A3 (en) Highly pure laquinimod or a pharmaceutically acceptable salt thereof
IL179719A0 (en) Process for preparation of amorphous form of drug
WO2008019782A3 (de) Dispersionen von nanoharnstoffen. enthaltend wirkstoffe
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
MY147202A (en) Compositions comprising organic compounds
AU2003221867A1 (en) Method for inhibiting corrosion by post-dip of coated parts
WO2008144320A3 (en) Opioid and methods of making and using the same
MX2007014963A (es) Composicion de liberacion modificada de al menos una forma de venlafaxina.
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
WO2005097192A3 (en) Active substance combination of a carbinol compound and an opioid
WO2007133790A3 (en) NF-ϰB INHIBITORS AND USES THEREOF
IL182768A0 (en) Drug combination comprising a selective serotonin reuptake inhibitor and glucocorticoid receptor antagonist for the treatment of depression